Eve Holding, Inc. current report, 16 November 2020

Abrir documento

Business Context and Reporting Period

This Form 8-K was filed by Zanite Acquisition Corp., a special purpose acquisition company (SPAC), with a report date of November 19, 2020 and earliest event date of November 16, 2020. The request identifies the company as Eve Holding, Inc.; the filing itself does not use that name, so the corporate-name linkage should be verified.

The filing reports the closing of the company’s initial public offering, related private warrant financing, board appointments, governance documents, and establishment of the trust account. It does not report operating results for Eve Holding or another operating business.

Key Financial Metrics and Capitalization

  • IPO: 23,000,000 units were sold at $10.00 per unit, including 3,000,000 units issued upon full exercise of the underwriters’ over-allotment option.
  • IPO gross proceeds: $230.0 million.
  • Unit securities: Each unit included one Class A common share and one-half of one redeemable warrant. Each whole warrant is exercisable for one Class A share at $11.50 per share, subject to adjustment.
  • Private placement: 9,650,000 warrants were sold to Zanite Sponsor LLC at $1.00 per warrant, for stated gross proceeds of $9.65 million.
  • Trust account: $232.3 million was deposited with J.P. Morgan Chase Bank, N.A., consisting of $225.4 million from the IPO, including $8.05 million of deferred underwriting discount, and $6.9 million from the private placement warrants.
  • Revenue, profit, cash flow, margins, and debt: The filing text does not provide clear values for these operating or financial metrics. It is a transaction and corporate-events filing rather than an earnings report.

Material Changes and Corporate Actions

  • The IPO and private warrant placement were completed on November 16, 2020.
  • John B. Veihmeyer, Larry R. Flynn, and Gerard J. DeMuro were appointed as independent directors and assigned to the Audit Committee and Compensation Committee.
  • The company adopted an Amended and Restated Certificate of Incorporation.
  • Each newly appointed director entered into a letter agreement and indemnity agreement. The Sponsor had previously transferred 150,000 Class B shares to each of the three directors.
  • The company entered into underwriting, warrant, trust, registration rights, private warrant purchase, administrative services, and related governance agreements.

Guidance, Outlook, Risks, and Unusual Items

  • The filing does not provide revenue or earnings guidance, an operating forecast, or management projections.
  • The trust funds are restricted primarily for the completion of an initial business combination, permitted share redemptions, or liquidation if a business combination is not completed.
  • The company was required to complete its initial business combination within six months of the IPO closing, subject to possible automatic extensions to 12 or 18 months under specified terms. If not completed within 24 months, public shares generally become subject to redemption, subject to applicable law.
  • Interest on trust funds may be released for taxes and up to $100,000 for dissolution expenses.
  • Private placement warrants have terms differing from public warrants while held by the Sponsor or permitted transferees, including non-redeemability, transfer restrictions until 30 days after the business combination, cashless exercise rights, and registration rights.
  • The trust-account composition does not equal the full $239.65 million of stated IPO and private placement gross proceeds; the filing attributes $232.3 million to the trust account. The treatment of the difference should be verified against the registration statement and closing financial statements.

Facts Investors Should Verify

  1. Whether Zanite Acquisition Corp. subsequently became Eve Holding, Inc., and the effective date and terms of any merger or name change.
  2. The final use and reconciliation of IPO and private placement proceeds, including underwriting discounts, offering expenses, and the $232.3 million trust deposit.
  3. The applicable business-combination deadline, extension mechanics, and redemption rights under the Amended Charter.
  4. The dilution implications of 23.0 million public units, 9.65 million private placement warrants, Sponsor shares, and other securities.
  5. The complete warrant terms, including redemption provisions, adjustments, transfer restrictions, and cashless exercise rights.
  6. Subsequent filings for the target business, operating performance, merger terms, and any material risks not addressed in this IPO-closing report.